
Sciences of Phytochemistry
Archive Issues
Explore all published volumes and issues for SCIPHY.
Volume 5
Volume 4
Volume 3
Volume 2
July 2023 - December 2023
"This issue contains all the articles that are published between July 2023 and December 2023."
January 2023 - June 2023
"This issue (Volume 2 Issue 1) is open for submission. This issue covers any article that will be published during January 2023 - June 2023."
Volume 1
September - December 2022
"This issue contains 1 original article, 2 review articles, 1 opinion article, and 1 opinion/editorial article."
June - August 2022
"This issue contains 2 original articles, 2 review articles, and 1 mini-review."
Journal Key Facts
Publishing Fee (APC)
No Charge
Open Access License
CC BY 4.0
Language
English
Overview
Sciences of Phytochemistry (Sci. Phytochem.) is an international, peer-reviewed journal published by ETFLIN, dedicated to advancing research in all aspects of phytochemistry and plant-derived bioactive compounds. The journal provides a platform for the dissemination of original research, reviews, and scientific communications that explore the chemistry, biological activities, and applications of natural products derived from plants. We welcome contributions that deepen the understanding of the chemical diversity of plants and their potential in pharmaceuticals, nutraceuticals, agriculture, cosmetics, and environmental sustainability.
Latest Articles
Recently published research articles, review papers, and technical notes from the current volume of the journal.
- research article
Phytochemical Screening and Antioxidant Activity of Mimosa tenuiflora (Willd. ) Poir Root Extracts.
Victor Wagner Barajas-Carrillo, Carlos Eduardo Covantes-Rosales, Valeria Estefanía Castrejón-Medina, Alexander Manuel Mendoza-Martínez, Saul Toledo, Adela Yolanda Bueno-Durán, Mercedes Zambrano-Soria, Karina Janice Guadalupe Díaz-Resendiz, Laura Janeth Díaz-Rubio, Iván Córdova-Guerrero
This study evaluated the phytochemical profile and antioxidant activity of extracts and partitions derived from the root of Mimosa tenuiflora (Willd. ) Poir. , also known as tepezcohuite. Three extracts were prepared through hydroalcoholic maceration, total alkaloid extraction, and Soxhlet extraction. Additionally, four partitions were obtained from the ethanolic extract using the modified Kupchan technique: n-hexane, dichloromethane, n-butanol, and water. Qualitative phytochemical screening showed the presence of alkaloids, tannins, flavonoids, saponins, steroids, triterpenoids, reducing sugars, coumarins, and cardiac glycosides in various several fractions, while no anthraquinone glycosides were detected. Antioxidant activity was assessed using DPPH and ABTS assays. In the DPPH assay, the most active fractions were the butanolic (EC50 = 2.20 ± 0.45 µg/mL) and the ethanolic (EC50 = 2.25 ± 0.01 µg/mL). While, in the ABTS assay, the ethanolic extract and butanol partition were the most active fractions with EC50 values of 4.87 ± 1.11 µg/mL and 5.43 ± 0.21 µg/mL respectively. The less polar fractions (n-hexane, Soxhlet) exhibited lower activity. This study expands the phytochemical knowledge of M. tenuiflora, focusing on its roots, an organ less extensively characterized than the bark regarding its comprehensive phytochemical and antioxidant profile. The results show that this organ is a promising source of bioactive metabolites with antioxidant capacity. This finding justifies further investigation into the pharmacological and therapeutic applications of these compounds, which is particularly relevant given that while previous research has systematically favored the bark, and existing root studies have focused primarily on specific alkaloids, comprehensive profiling remains limited.
Sciences of Phytochemistry
6 Apr 202612 pages - research article
A Computational Investigation of Cathinone, the Major Psychotropic Alkaloid from Muguka (a Cultivar of Catha edulis), Co-administered with Diazepam
Mohamed Said Rajab
Muguka, a high-cathinone cultivar of Catha edulis consumed widely in East Africa, presents a growing health risk when co-administered with diazepam. This theoretical study represents one of the first integrated computational investigations focusing on the interaction between Muguka derived cathinone and diazepam, combining molecular docking, ADMET profiling, and physiologically based pharmacokinetic (PBPK) modeling. The in silico analysis identified overlapping CYP2D6 and CYP2C19 pathways, supporting potential mutual metabolic inhibition. The predictive PBPK models suggest moderate CYP2D6/CYP2C19-mediated drug-drug interactions based on a simulated oral dose of 100 mg cathinone and 30 mg diazepam in a human adult population. Co-administration is predicted to increase cathinone systemic exposure by 1.5-fold (AUC ↑50%) and reduce clearance by 33%, while diazepam exposure is projected to rise by 1.3-fold (AUC ↑30%) with 24% clearance reduction. Molecular docking revealed high-affinity binding of cathinone (-6.4 kcal/mol) at the dopamine transporter (DAT) and diazepam (-6.8 kcal/mol) at the γ-aminobutyric acid-A (GABA-A) receptor, indicating distinct yet potentially complementary CNS targets. Collectively, these computational predictions suggest that co-use may prolong CNS exposure and theoretically enhance neurotoxicity, and dependence risk. This integrated computational framework provides a hypothetical mechanistic evidence for stimulant-benzodiazepine interactions and underscores the need for clinical monitoring and validation.
Sciences of Phytochemistry
25 Feb 20269 pages - research article
Phytochemical Analysis, Antinociceptive and Anti-inflammatory Activities of Mimusops elengi Bojer Leaf Extract-loaded Chitosan Nanoparticles in Albino Mice
Cletus Anes Ukwubile, Chidi Kaosi Clement
The present study evaluated the antinociceptive and anti-inflammatory activities of Mimusops elengi Bojer leaf extract encapsulated in chitosan nanoparticles (CS-NPs) using murine models, to determine whether nanoparticle formulation enhances the biological effects of a methanolic plant extract. Preliminary phytochemical screening was conducted using established qualitative colorimetric assays, which indicated the presence of major secondary metabolite classes, including phenolics and flavonoids; these tests were intended for compositional inference rather than definitive compound identification. Total phenolic and flavonoid contents were subsequently quantified using spectrophotometric methods, yielding 806.12 mg gallic acid equivalents (GAE)/g and 103.08 mg quercetin equivalents (QE)/g of extract, respectively. Antinociceptive activity was assessed using acetic acid–induced writhing and hot-plate assays, while anti-inflammatory effects were evaluated via the carrageenan-induced paw edema model. Animals treated with M. elengi–loaded CS-NPs exhibited statistically significant reductions in writhing responses, prolonged pain reaction latency, and decreased paw edema when compared with untreated controls and animals receiving the crude extract (p < 0.05). Inflammatory mediator analysis further demonstrated significant downregulation of pro-inflammatory cytokines (TNF-α, IL-1β, and PGE₂) alongside upregulation of anti-inflammatory cytokines (IL-10 and IL-22). Oxidative stress assessment showed reduced malondialdehyde (MDA) levels, indicating attenuation of lipid peroxidation. All experiments were conducted with appropriate replication, and data were subjected to statistical analysis to ensure reproducibility. While the phytochemical screening provides preliminary compositional insights, the observed pharmacological effects are attributed to the combined action of extract constituents and improved delivery via chitosan nanoparticles. Overall, the findings support the hypothesis that nanoparticle-based formulation can enhance the antinociceptive and anti-inflammatory efficacy of M. elengi leaf extract, highlighting its potential as a complementary therapeutic approach while underscoring the need for further compound-level characterization and safety evaluation.
Sciences of Phytochemistry
22 Jan 202613 pages - research article
Phytochemical Characterization and Evaluation of Antioxidant Activity in Sorghum bicolor Leaves Extracts
Poro David Clark, Gloria Ihuoma Ndukwe, Kehinde Jonathan Awatefe
This study investigated the phytochemical composition and in-vitro antioxidant potential of leaves extracts from Sorghum bicolor, which were obtained through sequential maceration with solvents of different polarities (n-hexane and methanol). The extraction yields revealed a predominance of polar compounds, with methanol extract (12.5% w/w) significantly higher than the n-hexane extract (1.7% w/w). Gas chromatography–mass spectrometry (GC–MS) profiling, using NIST library matching (similarity scores > 80%) without reference standards, showed distinct patterns based on solvent use: the n-hexane extract contained nine primarily lipophilic compounds, mainly consisting of Z-2-octadecen-1-ol and octadecenoic acid derivatives, whereas the methanol extract yielded fifteen characterized by polar fatty acids and oxygenated derivatives. Identifications were tentative; those with lower match scores or inconsistent retention times required confirmation through alternative methods. Antioxidant capacity was evaluated via 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, hydroxyl radical inhibitory activity (HRIA), and ferric reducing antioxidant power (FRAP) assays. The methanol extract demonstrated concentration-dependent DPPH scavenging (IC₅₀ = 0.1402 mg/L), comparable to vitamin C (0.1369 mg/L) in this assay, while the n-hexane extract showed weaker activity (IC₅₀ 3.22 mg/L). In HRIA and FRAP assays, vitamin C consistently showed greater activity than either extract, with n-hexane IC50 estimates constrained by poor curve fits (R2< 0.9). Overall, the methanol extract surpassed the n-hexane extract across all assays but did not match the effectiveness of vitamin C. These in-vitro results suggest that S. bicolor leaves contain polar phytochemicals that merit further fractionation, compound-level characterization, and evaluation in biologically relevant models to elucidate their potential as sources of natural antioxidants.
Sciences of Phytochemistry
17 Feb 202612 pages - research article
Ethnobotany, Phytochemistry, Pharmacology, and Toxicology of Cycas revoluta Thunb.: An Updated Review
Abdul Jaleel K, Prakash PS, Nakshathra KV, Devika V
Cycas revoluta Thunb. (sago palm), a cycad native to southern Japan, is widely cultivated and has a long history of ethnobotanical use, including as a famine food and in traditional medicine, but is also well known for its pronounced toxicity to humans and animals. This review critically synthesizes literature published between 1958–2025 on the ethnobotany, phytochemistry, pharmacology, and toxicology of C. revoluta from ScienceDirect, PubMed, Scopus, and Google Scholar. Presented as a structured narrative review, the study highlights diverse phytochemicals, including biflavonoids, cycasin, β-N-methylamino-L-alanine (BMAA), and reported antimicrobial peptides, noting variability in compound verification and reproducibility. Reported pharmacological activities are derived mainly from in vitro and preclinical studies, with limited in vivo validation and no established clinical relevance, whereas toxicological evidence for neurotoxicity, genotoxicity, and hepatotoxicity is robust. This imbalance underscores the need for caution in extrapolating therapeutic potential. Key gaps include inadequate extract standardization, limited bioavailability and safety data, and overreliance on single-study findings. Future research should prioritize rigorous toxicological assessment and reproducible validation before any translational application is considered. In addition, the review emphasizes the importance of distinguishing traditional knowledge from experimentally validated evidence and separating descriptive phytochemical inventories from mechanistic and translational insights. Particular attention is given to methodological limitations, including inconsistent extraction protocols, insufficient structural confirmation of reported compounds, and the frequent absence of dose–response, pharmacokinetic, and long-term safety evaluations. By adopting a critical and balanced perspective, this review aims to guide future studies toward scientifically rigorous, ethically responsible, and clinically relevant research directions.
Sciences of Phytochemistry
28 Jan 202610 pages

